Nature's Sunshine Products Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $492M+8.3% YoYTTM through 30 Jun 2026
Net Income $18.1M+135.1% YoYTTM through 30 Jun 2026
Free Cash Flow $18.1MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 73.2% |
| EBITDA Margin | 8.7% |
| Operating Margin | 7.7% |
| Net Margin | 3.7% |
Returns
10.7%ROE
7.0%ROA
20.8%ROIC
Balance Sheet Health
Debt / Equity0.00x
Current Ratio2.60x
Net Debt-$93.9Mnet cash position
Cash & Equivalents$82.5M
Quality Metrics
Altman Z-Score4.78
Piotroski F-Score8 / 9
FCF Margin3.7%
Rule of 406.6
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $480.1M
Diluted EPS$1.00TTMFY2025: $1.06
Dividend
$1.00Per share, FY20210.00%Yield1 yrsStreak
Capital Allocation
R&D Spend$1.9M
Capex Intensity1.9%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Asia Pacific | $52.2M | +7.0% | |
| North America | $143.6M | +3.4% | View detailsContinued mid- to high single-digit revenue growth is anticipated in North America throughout 2026. |
| Europe | $26.4M | +9.5% | View detailsEurope is expected to see mid-single-digit growth for the remainder of 2026. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.